BioCentury
ARTICLE | Clinical News

Humira adalimumab regulatory update

August 16, 2004 7:00 AM UTC

FDA approved an expanded indication for Humira to include improvement in physical function in adult patients with moderate to severe rheumatoid arthritis (RA). The monoclonal antibody against tumor n...